NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase Neogen Corporation NEOG Q1 2026 Earnings Strong EPS Surprise Drives 53 Beat Above Estimates Veracyte VCYT Q1 2026 Earnings Stellar EPS Beat Overshadowed by Modest Stock Decline RKDA Q3 2025 Earnings Stunning EPS Surprise Driven by NonRecurring Items Stock Rallies GBCI Q1 2026 Earnings EPS Misses Expectations Amid Challenging Operating Environment IsoEnergy Q1 2026 Earnings Narrower Than Expected Loss as Uranium Developer Advances Projects